Spironolactone alleviates late cardiac remodeling after left ventricular restoration surgery

Journal of Thoracic and Cardiovascular Surgery

Volumn 136, Issue 1, 2008, Pages 58-64

  Tsukashita, Masaki ^a   Marui, Akira ^a   Nishina, Takeshi ^a   Yoshikawa, Eiji ^a   Kanemitsu, Hideo ^b   Wang, Jian ^a   Ikeda, Tadashi ^a   Komeda, Masashi ^a  

^a KYOTO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b HAMAMATSU ROSAI HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN NATRIURETIC PEPTIDE; MESSENGER RNA; SPIRONOLACTONE; TRANSFORMING GROWTH FACTOR BETA1;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD PRESSURE; CONTROLLED STUDY; ECHOCARDIOGRAPHY; FIBROSING ALVEOLITIS; HEART LEFT VENTRICLE ANEURYSM; HEART LEFT VENTRICLE ENDDIASTOLIC PRESSURE; HEART LEFT VENTRICLE FUNCTION; HEART RATE; HEART SURGERY; HEART VENTRICLE REMODELING; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; REAL TIME POLYMERASE CHAIN REACTION; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM;

ALDOSTERONE ANTAGONISTS; ANIMALS; HEART ANEURYSM; HEART VENTRICLES; HEMODYNAMICS; LUNG; MALE; MYOCARDIAL INFARCTION; MYOCARDIUM; NATRIURETIC PEPTIDE, BRAIN; ORGAN SIZE; RATS; RATS, SPRAGUE-DAWLEY; RECURRENCE; SPIRONOLACTONE; TRANSFORMING GROWTH FACTOR BETA1; VENTRICULAR DYSFUNCTION, LEFT; VENTRICULAR REMODELING;

EID: 46049084581     PISSN: 00225223     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jtcvs.2007.11.016     Document Type: Article

References (25)

1. Komeda M., David T.E., Malik A., Ivanov J., and Sun Z. Operative risks and long-term results of operation for left ventricular aneurysm. Ann Thorac Surg 53 (1992) 22-29
2. Mickleborough L.L., Maruyama H., Liu P., and Mohamed S. Results of left ventricular aneurysmectomy with a tailored scar excision and primary closure technique. J Thorac Cardiovasc Surg 107 (1994) 690-698
3. Kesler K.A., Fiore A.C., Naunheim K.S., Sharp T.G., Mahomed Y., Zollinger T.W., et al. Anterior wall left ventricular aneurysm repair. A comparison of linear versus circular closure. J Thorac Cardiovasc Surg 103 (1992) 841-848
4. Di Donato M., Barletta G., Maioli M., Fantini F., Coste P., Sabatier M., et al. Early hemodynamic results of left ventricular reconstructive surgery for anterior wall left ventricular aneurysm. Am J Cardiol 69 (1992) 886-890
5. Dor V., Saab M., Coste P., Kornaszewska M., and Montiglio F. Left ventricular aneurysm: a new surgical approach. Thorac Cardiovasc Surg 37 (1989) 11-19
6. Dor V., Sabatier M., Di Donato M., Montiglio F., Toso A., and Maioli M. Efficacy of endoventricular patch plasty in large postinfarction akinetic scar and severe left ventricular dysfunction: comparison with a series of large dyskinetic scars. J Thorac Cardiovasc Surg 116 (1998) 50-59
7. Nishina T., Nishimura K., Yuasa S., Miwa S., Nomoto T., Sakakibara Y., et al. Initial effects of the left ventricular repair by plication may not last long in a rat ischemic cardiomyopathy model. Circulation 104 (2001) I241-I245
8. Sinatra R., Macrina F., Braccio M., Melina G., Luzi G., Ruvolo G., et al. Left ventricular aneurysmectomy; comparison between two techniques; early and late results. Eur J Cardiothorac Surg 12 (1997) 291-297
9. Nomoto T., Nishina T., Miwa S., Tsuneyoshi H., Maruyama I., Nishimura K., et al. Angiotensin-converting enzyme inhibitor helps prevent late remodeling after left ventricular aneurysm repair in rats. Circulation 106 (2002) I115-I119
10. Tsuneyoshi H., Nishina T., Nomoto T., Kanemitsu H., Kawakami R., Unimonh O., et al. Atrial natriuretic peptide helps prevent late remodeling after left ventricular aneurysm repair. Circulation 110 (2004) II174-II179
11. Nomoto T., Nishina T., Tsuneyoshi H., Miwa S., Nishimura K., and Komeda M. Effects of two inhibitors of renin-angiotensin system on attenuation of postoperative remodeling after left ventricular aneurysm repair in rats. J Card Surg 18 Suppl 2 (2003) S61-S68
12. White H.D., Aylward P.E., Huang Z., Dalby A.J., Weaver W.D., Barvik S., et al. Mortality and morbidity remain high despite captopril and/or Valsartan therapy in elderly patients with left ventricular systolic dysfunction, heart failure, or both after acute myocardial infarction: results from the Valsartan in Acute Myocardial Infarction Trial (VALIANT). Circulation 112 (2005) 3391-3399
13. Pitt B., Zannad F., Remme W.J., Cody R., Castaigne A., Perez A., et al. The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators. N Engl J Med 341 (1999) 709-717
14. Nishina T., Nishimura K., Yuasa S., Miwa S., Sakakibara Y., Ikeda T., et al. A rat model of ischemic cardiomyopathy for investigating left ventricular volume reduction surgery. J Card Surg 17 (2002) 155-162
15. Matsumoto R., Yoshiyama M., Omura T., Kim S., Nakamura Y., Izumi Y., et al. Effects of aldosterone receptor antagonist and angiotensin II type I receptor blocker on cardiac transcriptional factors and mRNA expression in rats with myocardial infarction. Circ J 68 (2004) 376-382
16. Silvestre J.S., Heymes C., Oubenaissa A., Robert V., Aupetit-Faisant B., Carayon A., et al. Activation of cardiac aldosterone production in rat myocardial infarction: effect of angiotensin II receptor blockade and role in cardiac fibrosis. Circulation 99 (1999) 2694-2701
17. Suga H., and Sagawa K. Instantaneous pressure-volume relationships and their ratio in the excised, supported canine left ventricle. Circ Res 35 (1974) 117-126
18. Weiss J.L., Frederiksen J.W., and Weisfeldt M.L. Hemodynamic determinants of the time-course of fall in canine left ventricular pressure. J Clin Invest 58 (1976) 751-760
19. Pitt B., Poole-Wilson P.A., Segal R., Martinez F.A., Dickstein K., Camm A.J., et al. Effect of losartan compared with captopril on mortality in patients with symptomatic heart failure: randomised trial-the Losartan Heart Failure Survival Study ELITE II. Lancet 355 (2000) 1582-1587
20. Mill J.G., Milanez Mda C., de Resende M.M., Gomes Mda G., and Leite C.M. Spironolactone prevents cardiac collagen proliferation after myocardial infarction in rats. Clin Exp Pharmacol Physiol 30 (2003) 739-744
21. Hayashi M., Tsutamoto T., Wada A., Tsutsui T., Ishii C., Ohno K., et al. Immediate administration of mineralocorticoid receptor antagonist spironolactone prevents post-infarct left ventricular remodeling associated with suppression of a marker of myocardial collagen synthesis in patients with first anterior acute myocardial infarction. Circulation 107 (2003) 2559-2565
22. Lal A., Veinot J.P., and Leenen F.H. Critical role of CNS effects of aldosterone in cardiac remodeling post-myocardial infarction in rats. Cardiovasc Res 64 (2004) 437-447
23. Modena M.G., Aveta P., Menozzi A., and Rossi R. Aldosterone inhibition limits collagen synthesis and progressive left ventricular enlargement after anterior myocardial infarction. Am Heart J 141 (2001) 41-46
24. Jorde U.P., Vittorio T., Katz S.D., Colombo P.C., Latif F., and Le Jemtel T.H. Elevated plasma aldosterone levels despite complete inhibition of the vascular angiotensin-converting enzyme in chronic heart failure. Circulation 106 (2002) 1055-1057
25. Katada J., Meguro T., Saito H., Ohashi A., Anzai T., Ogawa S., et al. Persistent cardiac aldosterone synthesis in angiotensin II type 1A receptor-knockout mice after myocardial infarction. Circulation 111 (2005) 2157-2164